Group 1: Earnings Performance - AdaptHealth Corp. reported quarterly earnings of $0.01 per share, matching the Zacks Consensus Estimate, compared to $0.02 per share a year ago [1] - The company posted revenues of $777.88 million for the quarter, exceeding the Zacks Consensus Estimate by 1.72%, but down from $792.5 million year-over-year [2] - Over the last four quarters, AdaptHealth has surpassed consensus EPS estimates three times [1][2] Group 2: Stock Performance and Outlook - AdaptHealth shares have declined approximately 8.6% since the beginning of the year, while the S&P 500 has decreased by 3.9% [3] - The company's earnings outlook will be crucial for future stock movements, with current consensus EPS estimates at $0.28 for the coming quarter and $1.12 for the current fiscal year [4][7] - The current Zacks Rank for AdaptHealth is 3 (Hold), indicating expected performance in line with the market in the near future [6] Group 3: Industry Context - The Medical - Products industry, to which AdaptHealth belongs, is currently ranked in the bottom 26% of over 250 Zacks industries, which may impact stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that investors should monitor these revisions closely [5]

Premier, Inc. (PINC) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.55 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 41.94%. A quarter ago, it was expected that this company would post earnings of $0.29 per share when it actually produced earnings of $0.27, delivering a surprise of -6.90%.Over the last four quarters, the company ha ...

Group 1 - Enlight Renewable Energy Ltd. reported quarterly earnings of $0.75 per share, exceeding the Zacks Consensus Estimate of $0.65 per share, and showing significant growth from $0.14 per share a year ago, resulting in an earnings surprise of 15.38% [1] - The company achieved revenues of $129.87 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 11.95% and increasing from $90.4 million year-over-year [2] - Enlight Renewable Energy Ltd. has consistently surpassed consensus EPS estimates over the last four quarters, indicating strong performance [2] Group 2 - The stock has underperformed the market, losing about 5.7% since the beginning of the year compared to the S&P 500's decline of 3.9% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the coming quarter is $0.09 on revenues of $125.19 million, and for the current fiscal year, it is $0.91 on revenues of $501.56 million [7] Group 3 - The Zacks Industry Rank indicates that the Alternative Energy - Other sector is currently in the bottom 41% of over 250 Zacks industries, which may negatively impact stock performance [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that tracking these revisions can be beneficial for investors [5] - The current estimate revisions trend for Enlight Renewable Energy Ltd. is mixed, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6]

Group 1: Earnings Performance - Celsius Holdings Inc. reported quarterly earnings of $0.18 per share, missing the Zacks Consensus Estimate of $0.20 per share, and down from $0.27 per share a year ago, representing an earnings surprise of -10% [1] - The company posted revenues of $329.28 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 3.62%, and down from $355.71 million year-over-year [2] Group 2: Stock Performance and Outlook - Celsius shares have increased approximately 28.7% since the beginning of the year, contrasting with the S&P 500's decline of -3.9% [3] - The current consensus EPS estimate for the upcoming quarter is $0.29 on revenues of $633.89 million, and for the current fiscal year, it is $0.99 on revenues of $2.18 billion [7] Group 3: Industry Context - The Zacks Industry Rank for Food - Miscellaneous is currently in the top 31% of over 250 Zacks industries, indicating that the industry outlook can significantly impact stock performance [8]

Core Insights - Waters (WAT) reported quarterly earnings of $2.25 per share, exceeding the Zacks Consensus Estimate of $2.22 per share, and showing a slight increase from $2.21 per share a year ago, resulting in an earnings surprise of 1.35% [1] - The company achieved revenues of $661.71 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 1.08% and reflecting a year-over-year increase from $636.84 million [2] - Waters has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] Earnings Outlook - The future performance of Waters' stock will largely depend on management's commentary during the earnings call and the sustainability of the stock's price movement based on recent earnings and future expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $2.93, with projected revenues of $737.31 million, and for the current fiscal year, the consensus EPS is $12.84 on revenues of $3.08 billion [7] Industry Context - The Medical - Instruments industry, to which Waters belongs, is currently ranked in the top 25% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked using tools like the Zacks Rank [5][6]

Primoris Services (PRIM) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $0.47 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 36.11%. A quarter ago, it was expected that this construction contractor would post earnings of $0.73 per share when it actually produced earnings of $1.13, delivering a surprise of 54.79%.Over the last four quar ...

Core Insights - Accel Entertainment reported quarterly earnings of $0.24 per share, exceeding the Zacks Consensus Estimate of $0.18 per share, and showing an increase from $0.22 per share a year ago, resulting in an earnings surprise of 33.33% [1] - The company achieved revenues of $323.91 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.89% and up from $301.82 million year-over-year [2] - The stock has underperformed slightly, losing about 0.3% since the beginning of the year, compared to a decline of 3.3% in the S&P 500 [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.22 on revenues of $331.38 million, and for the current fiscal year, it is $0.81 on revenues of $1.32 billion [7] - The estimate revisions trend for Accel Entertainment is currently unfavorable, leading to a Zacks Rank 4 (Sell), indicating expected underperformance in the near future [6] Industry Context - The Gaming industry, to which Accel Entertainment belongs, is currently ranked in the bottom 32% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Another company in the same industry, Playtika Holding, is expected to report quarterly earnings of $0.11 per share, reflecting a year-over-year decline of 26.7%, with revenues projected at $697.25 million, up 7.1% from the previous year [9][10]

Core Viewpoint - Interparfums reported quarterly earnings of $1.32 per share, exceeding the Zacks Consensus Estimate of $1.13 per share, and showing an increase from $1.27 per share a year ago, representing an earnings surprise of 16.81% [1][2] Financial Performance - The company achieved revenues of $338.82 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.47% and increasing from $323.96 million year-over-year [2] - Over the last four quarters, Interparfums has consistently surpassed consensus EPS estimates [2] Stock Performance - Interparfums shares have declined approximately 14.1% since the beginning of the year, compared to a decline of 3.3% for the S&P 500 [3] - The current Zacks Rank for Interparfums is 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The consensus EPS estimate for the upcoming quarter is $1.24 on revenues of $358.05 million, and for the current fiscal year, it is $5.34 on revenues of $1.51 billion [7] - The trend of estimate revisions for Interparfums is currently mixed, which may change following the recent earnings report [6] Industry Context - The Consumer Products - Discretionary industry, to which Interparfums belongs, is currently ranked in the bottom 24% of over 250 Zacks industries, indicating potential challenges ahead [8]

Core Insights - Corcept Therapeutics reported quarterly earnings of $0.17 per share, matching the Zacks Consensus Estimate, but down from $0.25 per share a year ago [1] - The company posted revenues of $157.21 million for the quarter, missing the Zacks Consensus Estimate by 11.66%, compared to $146.81 million in the same quarter last year [2] - Corcept shares have increased by approximately 44.4% since the beginning of the year, contrasting with a -3.3% decline in the S&P 500 [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.40 on revenues of $216.49 million, and for the current fiscal year, it is $1.76 on revenues of $905.68 million [7] - The estimate revisions trend for Corcept is mixed, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Medical - Drugs industry, to which Corcept belongs, is currently ranked in the top 25% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Viewpoint - EverQuote (EVER) reported quarterly earnings of $0.38 per share, exceeding the Zacks Consensus Estimate of $0.32 per share, and showing significant growth from $0.05 per share a year ago, indicating strong performance in the insurance sector [1][2]. Financial Performance - The company achieved revenues of $166.63 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 5.41%, and up from $91.07 million year-over-year [2]. - Over the last four quarters, EverQuote has consistently exceeded consensus EPS estimates, demonstrating a strong earnings performance [2]. Stock Performance - EverQuote shares have increased approximately 33.6% since the beginning of the year, contrasting with a decline of -3.3% in the S&P 500 [3]. - The stock currently holds a Zacks Rank 1 (Strong Buy), indicating expectations for continued outperformance in the near future [6]. Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.29 on revenues of $150.15 million, and for the current fiscal year, it is $1.20 on revenues of $626.23 million [7]. - The insurance industry, particularly the Insurance - Multi line sector, is currently ranked in the top 25% of Zacks industries, suggesting a favorable environment for stock performance [8].